Palmitoyl Tripeptide-5

Nov 9, 2023 Syn-Coll, or Palmitoyl Tripeptide-5, stands as a synthetic peptide under scientific investigation for its potential capacity to bolster the production of collagen type I. Through its mechanism of action, this peptide has exhibited potential to minimize wrinkle depth, and possibly provide support in accelerating natural protein production which contribute to the firming and hydration of the skin. Notably, its functioning appears to be linked to the stimulation of transforming growth factor-β (TGF-β).(1) The speculated resemblance between Syn-Coll and the effects of TSP-1, an intrinsic component within the extracellular matrix (ECM), is critical. The core sequence Lys-Arg-Phe-Lys within the structure of thrombospondin-1 (TSP-1) is widely recognized as the stimulator for transforming growth factor-β (TGF-β) activation.(2) As a striking parallel, Syn-Coll, comprising the sequence Palmitoyl-Lys-Val-Lys, has been implicated in potentially evoking similar responses in TGF-β. This interaction has led to observations from animal models and in vitro studies using dermal fibroblasts, indicating an increased propensity for Syn-Coll to stimulate the production of Type I and Type III collagen by dermal fibroblasts through the activation of TGF-β. One proposed mechanism cited in multiple bodies of research suggests that Syn-Coll possibly interferes with the activities of matrix metalloproteinase 1 and 3 (MMP1 and MMP3), enzymes that play a pivotal role in the natural degradation of collagen. While these enzymes are involved in the normal turnover of aging collagen, they may become notably upregulated during inflammatory states, potentially leading to premature skin damage and the emergence of wrinkles in the skin.